Literature DB >> 7589984

How are class II MHC genes turned on and off?

S A Abdulkadir1, S J Ono.   

Abstract

Fragments of foreign antigen are detected by CD4+ helper T cells via the T cell receptor for antigen in the context of major histocompatibility complex (MHC) class II molecules. Very few cells normally express class II MHC molecules, and these cells play critical roles in antigen presentation and in the thymic selection of T lymphocytes before their exit into the periphery. Because of the central role the class II MHC molecules play in immune system function, it is not surprising that the lack of expression of these molecules results in a severe combined immunodeficiency disorder (called bare lymphocyte syndrome) and that the aberrant expression of the molecules is frequently observed in the target organs of various autoimmune disorders (e.g., multiple sclerosis and rheumatoid arthritis). Because both classes of disease could conceivably be treated by molecular approaches targeted at either restoring or inhibiting expression of class II MHC genes, there has been an intense effort during the past decade to elucidate the regulatory mechanisms of class II MHC genes. An analysis of recent advances in this effort is provided in this review article.

Entities:  

Mesh:

Year:  1995        PMID: 7589984     DOI: 10.1096/fasebj.9.14.7589984

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

1.  Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.

Authors:  N Jabrane-Ferrat; J D Fontes; J M Boss; B M Peterlin
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

2.  Repression of MHC class II gene transcription in trophoblast cells by novel single-stranded DNA binding proteins.

Authors:  S P Murphy; S O Gollnick; T Pazmany; P Maier; G Elkin; T B Tomasi
Journal:  Mol Reprod Dev       Date:  1997-08       Impact factor: 2.609

3.  Chicken YB-2, a Y-box protein, is a potent activator of Rous sarcoma virus long terminal repeat-driven transcription in avian fibroblasts.

Authors:  S K Swamynathan; A Nambiar; R V Guntaka
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32.

Authors:  J D Fontes; B Jiang; B M Peterlin
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

Review 5.  The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis.

Authors:  F Liu; K Y Chau; P Arlotta; S J Ono
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  The architectural transcription factor high mobility group I(Y) participates in photoreceptor-specific gene expression.

Authors:  K Y Chau; N Munshi; A Keane-Myers; K W Cheung-Chau; A K Tai; G Manfioletti; C K Dorey; D Thanos; D J Zack; S J Ono
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

7.  Murine NFX.1: isolation and characterization of its messenger RNA, mapping of its chromosomal location and assessment of its developmental expression.

Authors:  Paola Arlotta; Dai Miyazaki; Neal G Copeland; Debra J Gilbert; Nancy A Jenkins; Santa J Ono
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

8.  Differential regulation of expression of the MHC class II molecules RT1.B and RT1.D on rat B lymphocytes: effects of interleukin-4, interleukin-13 and interferon-gamma.

Authors:  A Roos; E J Schilder-Tol; M A Chand; N Claessen; F G Lakkis; D W Pascual; J J Weening; J Aten
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

9.  Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes.

Authors:  J D Fontes; S Kanazawa; D Jean; B M Peterlin
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID).

Authors:  Barry R Zeeberg; Haiying Qin; Sudarshan Narasimhan; Margot Sunshine; Hong Cao; David W Kane; Mark Reimers; Robert M Stephens; David Bryant; Stanley K Burt; Eldad Elnekave; Danielle M Hari; Thomas A Wynn; Charlotte Cunningham-Rundles; Donn M Stewart; David Nelson; John N Weinstein
Journal:  BMC Bioinformatics       Date:  2005-07-05       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.